May 13, 2025
MANCHESTER, England — A soon-to-be-released guidance from the British Society for Rheumatology on the management of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) emphasizes not only the […]
May 12, 2025
TOPLINE: Although remission rates of patients with early rheumatoid arthritis (RA) remained stable between 2018 and 2024 in England and Wales, regional differences were noted. Factors […]
May 12, 2025
TOPLINE: In a cohort of 2000 patients with systemic sclerosis (SSc), 20% were found to have multimorbidity, primarily driven by cardiovascular disease and other important cardiovascular […]
May 12, 2025
TOPLINE: Prophylactic treatment with trimethoprim-sulfamethoxazole (TMP-SMX) significantly reduced the risk for serious infections by approximately 50% in patients with antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis, with the […]
May 12, 2025
TOPLINE: The risk for progression of rheumatoid arthritis–associated interstitial lung disease (RA-ILD) was higher in patients with a usual interstitial pneumonia (UIP) pattern, an ILD extent […]
May 7, 2025
TOPLINE: Carpal tunnel syndrome (CTS) appeared more than twice as frequently in patients before rheumatoid arthritis (RA) diagnosis than in those without RA, suggesting that CTS […]
May 6, 2025
MANCHESTER, England — Use of immunosuppressive drugs within 5 years of the onset of systemic sclerosis (SSc) did not lower patients’ risk for developing pulmonary arterial […]
May 6, 2025
INCHEON, South Korea — A shoe-based biomechanical intervention worn for a short time each day may achieve greater improvements in low back pain and greater reductions […]
May 6, 2025
INCHEON, South Korea — Defining early knee osteoarthritis (OA) as people who do not have symptoms but do have radiographic or MRI changes could offer greater […]